Medical oncologist <a href="http://www.upstate.edu/search/?tab=people&ID=morrisg&q=morris">Gloria Morris, MD, PhD</a>, and genetics program coordinator and nurse Rachael Grosvenor talk about ongoing experiments using a gene-editing technique called CRISPR to treat sickle cell disease. CRISPR, which stands for "clustered regularly interspaced short palindromic repeats," has potential for treating inherited cancers and other diseases.

Medical oncologist Gloria Morris, MD, PhD, and genetics program coordinator and nurse Rachael Grosvenor talk about ongoing experiments using a gene-editing technique called CRISPR to treat sickle cell disease. CRISPR, which stands for "clustered regularly interspaced short palindromic repeats," has potential for treating inherited cancers and other diseases.

Medical oncologist <a href="http://www.upstate.edu/search/?tab=people&amp;ID=morrisg&amp;q=morris" rel="noopener noreferrer">Gloria Morris, MD, PhD</a>, and genetics program coordinator and nurse Rachael Grosvenor talk about ongoing experiments using a gene-editing technique called CRISPR to treat sickle cell disease. CRISPR, which stands for "clustered regularly interspaced short palindromic repeats," has potential for treating inherited cancers and other diseases.

A look at CRISPR and the future of gene editing

The Informed Patient is Upstate Medical University's podcast on health, science and medicine, featuring experts from Central New York's only academic medical center.

Share A look at CRISPR and the future of gene editing

Sign up to save your podcasts

A look at CRISPR and the future of gene editing

A look at CRISPR and the future of gene editing